Laboratorios Farmaceuticos Rovi SA (XMAD:ROVI)
€ 88.2 0.4 (0.46%) Market Cap: 4.51 Bil Enterprise Value: 4.55 Bil PE Ratio: 33.53 PB Ratio: 8.48 GF Score: 88/100

Full Year 2019 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript

Feb 26, 2020 / 02:00PM GMT
Release Date Price: €25.2 (+1.20%)
Operator

Welcome to ROVI's Full Year 2019 Financial Results Presentation. The management of ROVI will run you through the presentation, which will be followed by a Q&A session. Mr. Juan López-Belmonte, Chief Executive Officer; and Mr. Javier López-Belmonte, Chief Financial Officer of ROVI, will be presenting this conference.

I will now pass the word to Mr. Javier López-Belmonte.

Javier López;Belmonte Encina;Juan López<
Laboratorios Farmaceuticos Rovi, S.A. - Second Deputy Chairman & CFO

So thank you very much, and good afternoon to everyone. This is Javier López-Belmonte, Chief Financial Officer of ROVI. At this time, I would like to welcome everybody to this full year 2019 results conference call, which will start in a moment.

Let me please first introduce ROVI's attendees today. Juan López-Belmonte, CEO; Marta Campos, Investor Relations; and myself. (Operator Instructions)

Let me now turn the call over to the CEO, Mr. Juan López-Belmonte, for the highlights of this full year 2019 results.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot